CuraSen Therapeutics, Inc.
Targeting neurodegeneration with novel science and treatments so patients can THINK, AGAIN
20 employees · est. 2017 · San Carlos, United States
Barinthus Biotherapeutics
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates.
34 employees · est. 2016 · Oxford, United Kingdom
Barinthus Biotherapeutics is the older company (2017 vs 2016).
Side-by-Side Comparison
| Metric | CuraSen Therapeutics, Inc. | Barinthus Biotherapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | San Carlos, United States | Oxford, United Kingdom |
| Employees | ||
| Employees | 20 | 34 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Medical Devices | Biotechnology, Health and Wellness, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Grant | Acquired |
| Total Funding | ||
| Total Funding | $95.90M | $146.66M |
| Funding Rounds | ||
| Funding Rounds | 5 | 7 |
| Services | ||
| Services | Research and Development, Drug Discovery, Clinical Pipeline Management | Development of antigen-specific immunotherapies, Phase 1b/2 clinical trials, Pipeline management for autoimmune diseases and chronic viral infections, Biopharmaceutical research and development |
| Target Customers | ||
| Target Customers | Healthcare Providers, Neurologists, Patients with Brain Diseases, Medical Researchers | Patients with autoimmune and inflammatory conditions, Patients with chronic viral infections, Healthcare providers, Oncologists |
| Taxonomy | ||
| Taxonomy | Neurodegenerative Diseases, Parkinson's Disease, Alzheimer's Disease, Orphan Drugs, Biopharmaceuticals, Locus Coeruleus, Clinical Development, Neuroscience, Pharmacology, Novel Therapeutics, Neuroinflammation, Neurometabolism, Cerebral Blood Flow, Chemical Entity Development, Investment Backing | T-cell Immunotherapeutics, Chronic Infectious Diseases, Autoimmunity, Cancer Treatment, ChAdOx Technology, MVA Boost Vector, SNAP-TI Platform, SNAP-CI Platform, CD8+ T Cells, Chronic HBV Treatment, Celiac Disease Treatment, Prostate Cancer Treatment, Viral Vaccine Development, Biopharmaceutical Innovation, Immunotherapeutic Pipeline |
| Website | ||
| Website | curasen.com | barinthusbio.com |
About CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company founded in 2017 and headquartered in the United States. The company's mission is encapsulated in its slogan: "Targeting neurodegeneration with novel science and treatments so patients can THINK, AGAIN." CuraSen focuses on de...
About Barinthus Biotherapeutics
Barinthus Biotherapeutics, founded in 2016, is a United Kingdom-based clinical-stage biopharmaceutical company that is innovating in the realms of Biotechnology, Health and Wellness, and Pharmaceutical industries. The company specializes in developing novel T-cell immunotherapeutic candidates aimed...
We will tell you when either one moves
BounceWatch watches CuraSen Therapeutics, Inc. and Barinthus Biotherapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at CuraSen Therapeutics,... and Barinthus Biotherapeut... — by email.
Frequently Asked Questions
Compare CuraSen Therapeutics, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at CuraSen Therapeutics, Inc. on 2 Mar 2026, and Barinthus Biotherapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
